Lonza’s innovative continuous flow technology and mini-monoplant approach are transforming early-phase drug development. How ...

The two companies have been working together since 2017, and, in 2021, they agreed to collaborate on NM26, a bispecific ...

An average drug candidate takes 10 to 15 years to progress through the development cycle. For every 5,000 compounds that ...

The path from a scientist’s initial idea to a new medicine that can save lives is a complex and often lengthy process. It ...

Evidence has been growing to suggest that tetrahydrocannabinol (THC), the main psychoactive ingredient in cannabis, poses risks to the developing fetus by impacting brain development. Now a new ...

23andMe's big push into drug development, announced with great fanfare almost a decade ago, has ended with a whimper and ...

CN Bio, a leading provider of Organ-on-a-chip Systems and solutions that accelerate drug discovery and development workflows, today announced the launch of its PhysioMimix® Bioavailability assay kit: ...

The rise of antibody therapeutics is transforming drug discovery, providing highly specific treatments for complex diseases ...

Preclinical proof-of-concept data supports the potential of CD3 Switch-DARPin platform to activate and boost T cells in the presence of tumor ...